C12Y 402/01078
-norcoclaurine synthase
Official title: (S)-norcoclaurine synthase (4.2.1.78)
C12Y402/01078 (-norcoclaurine synthase) appears on 1 US grants and 5 published applications in this corpus.
Search patents in C12Y- Granted patents
- 1
- Published applications
- 5
- Assignees
- 4
- Inventors
- 20
- Latest grant
- 21 Jan 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 2 |
| 2024 | 0 | 1 |
| 2025 | 1 | 1 |
By publication year.
Recent patents
- Norcoclaurine synthases with increased acitvity5 Jun 2025US 2025/0179543 A1River Stone Biotech, LLC
- Methods of improving production of morphinan alkaloids and derivatives28 Mar 2024US 2024/0102061 A1Antheia, Inc.
- Genetically modified host cells producing benzylisoquinoline alkaloids19 Oct 2023US 2023/0332195 A1River Stone Biotech Aps
- Norcoclaurine Synthases With Increased Activity22 Jun 2023US 2023/0193333 A1River Stone Biotech, LLC
- Recombinant host cell for producing benzylisoquinoline alkaloid (bia) and novel method for producing benzylisoquinoline alkaloid (bia)23 Dec 2021US 2021/0395717 A1National University Corporation Kobe University
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.